Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bourge

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Chest|July 23, 1998
Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodiumP F Castro, R C Bourge, D C McGiffin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 17, 1998
Risk of death or incapacitation after heart transplantation, with particular reference to pilotsD C McGiffin, D C Naftel, J L Spann, et al.
The American Journal of Cardiology|June 15, 1991
Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarctionM J Henzlova, R C Bourge, S E Papapietro, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist deviceW L Holman, R C Bourge, C P Murrah, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1990
Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3J K Kirklin, R C Bourge, C White-Williams, et al.
Echocardiography (Mount Kisco, N.Y.)|February 8, 1992
Application of echocardiographic color flow Doppler mitral regurgitation to the diagnosis of acute cardiac transplantation rejectionP Fan, J K Kirklin, D C Naftel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1992
Total lymphoid irradiation in the treatment of early or recurrent heart rejectionM M Salter, J K Kirklin, R C Bourge, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1992
Methotrexate pulse therapy in the treatment of recurrent acute heart rejectionR C Bourge, J K Kirklin, C White-Williams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2005
To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?R Higgins, J K Kirklin, R N Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1993
Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database GroupJ A Kobashigawa, J K Kirklin, D C Naftel, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Chest|July 23, 1998
Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodiumP F Castro, R C Bourge, D C McGiffin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 17, 1998
Risk of death or incapacitation after heart transplantation, with particular reference to pilotsD C McGiffin, D C Naftel, J L Spann, et al.
The American Journal of Cardiology|June 15, 1991
Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarctionM J Henzlova, R C Bourge, S E Papapietro, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist deviceW L Holman, R C Bourge, C P Murrah, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1990
Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3J K Kirklin, R C Bourge, C White-Williams, et al.
Echocardiography (Mount Kisco, N.Y.)|February 8, 1992
Application of echocardiographic color flow Doppler mitral regurgitation to the diagnosis of acute cardiac transplantation rejectionP Fan, J K Kirklin, D C Naftel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1992
Total lymphoid irradiation in the treatment of early or recurrent heart rejectionM M Salter, J K Kirklin, R C Bourge, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1992
Methotrexate pulse therapy in the treatment of recurrent acute heart rejectionR C Bourge, J K Kirklin, C White-Williams, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2005
To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?R Higgins, J K Kirklin, R N Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1993
Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database GroupJ A Kobashigawa, J K Kirklin, D C Naftel, et al.
Pageof 9